Dupilumab Subcutaneous and Hydrochlorothiazide and triamterene
Determining the interaction of Dupilumab Subcutaneous and Hydrochlorothiazide and triamterene and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: hydrochlorothiazide / triamterene
Brand name: Dyazide, Maxzide, Maxzide-25
Synonyms: Hydrochlorothiazide and Triamterene
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Hydrochlorothiazide and valsartan
- Dupilumab Subcutaneous-Hydrochlorothiazide Capsules
- Dupilumab Subcutaneous-Hydrochlorothiazide Tablets
- Dupilumab Subcutaneous-Hydrocil
- Dupilumab Subcutaneous-Hydrocodone
- Dupilumab Subcutaneous-Hydrocodone and acetaminophen
- Hydrochlorothiazide and triamterene-Dupixent
- Hydrochlorothiazide and triamterene-Duplex T Topical
- Hydrochlorothiazide and triamterene-Durachol
- Hydrochlorothiazide and triamterene-Duraclon
- Hydrochlorothiazide and triamterene-Duraclon injection
- Hydrochlorothiazide and triamterene-Duraflu